Maintaining target blood glucose levels helps protect the body’s
organs from damage. It also protects people living with type 1
diabetes from hypoglycaemia.
Insulin therapy aims to get as close as possible to the natural
insulin response of someone without diabetes. This can help people
living with type 1 diabetes maintain target blood glucose levels.
The closer insulin therapy gets to the body’s natural response, the
better it is at balancing blood glucose levels.
Insulin treatment has evolved significantly, and with each
advancement, we are closer to a natural insulin response. Most
importantly, these advancements helped people living with type 1
diabetes overcome some of the inconveniences that come with treating
and living with the disease.
One of our big ambitions is to develop so-called "smart
insulins" that will eliminate hypoglycaemic events. This would be
the next big breakthrough in type 1 diabetes care. We share this
ambition with many partners in the diabetes research community and
work closely with them towards a common goal – eliminating hypoglycaemia.